| abstract |
4- (2-Chloro-4-methoxy-5-methylphenyl) -N-[(1S) -2-cyclopropyl-1- (3-fluoro-4-methylphenyl) ethyl] -5-methyl-N- For the treatment of congenital adrenal hyperplasia in subjects in need thereof, including the step of administering propa-2-ynyl-1,3-thiazole-2-amine (formula I) or a pharmaceutically acceptable salt thereof. Related methods are provided. In addition, 4- (2-chloro-4-methoxy-5-methylphenyl) -N-[(1S) -2-cyclopropyl-1- (3-fluoro-) in the treatment of congenital adrenal hyperplasia (CAH). 4-Methylphenyl) ethyl] -5-methyl-N-propa-2-inyl-1,3-thiazole-2-amine or pharmaceutically acceptable salts thereof in pharmaceutical formulations and solid forms, as well as their use. Provided. |